Skip to main content
Equibles

GEODE CAPITAL MANAGEMENT, LLC

Position in LITS — Lite Strategy, Inc.

CIK 1214717 BOSTON, MA
Back to LITS Full portfolio

Position in LITS

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$335,817
-$129,448 QoQ
Shares Held
365,019
-9.0% QoQ
Ownership
1.20%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#5
of 35 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LITS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $22,039,296,497 across 521 Biotechnology names. LITS ranks #376 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,017,848 $2,989,245,636
2 REGN
Regeneron Pharmaceuticals, Inc.
 2,625,810 $1,637,297,566
3 ALNY
Alnylam Pharmaceuticals, Inc.
 2,635,840 $793,466,914
4 RVMD
Revolution Medicines, Inc.
 3,942,676 $738,384,360
5 MRNA
Moderna, Inc.
 9,710,335 $680,014,759
6 INCY
Incyte Corp
 4,750,735 $538,543,319
7 RPRX
Royalty Pharma plc
 8,058,048 $451,814,751
8 INSM
INSMED Inc
 4,220,155 $449,952,925

All Filings in LITS

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $335,817 365,019
2026-03-31 $465,265 401,091
2025-12-31 $437,417 331,377
2025-09-30 $567,663 234,572
2025-06-30 $141,169 57,154
2025-03-31 $126,434 57,733
2024-12-31 $145,648 59,207
2024-09-30 $169,010 59,302
2024-06-30 $149,253 51,290
2024-03-31 $209,724 52,431
2023-12-31 $299,372 51,616
2023-09-30 $350,415 49,988
2023-06-30 $314,741 47,833